(Q38229965)
Statements
1 reference
Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis (English)
1 reference
1 July 2014
1 reference